Next-Generation Antibody Therapeutics for Challenging Targets

HumiNex develops differentiated antibody therapeutics by integrating discovery, internalization, and Fc engineering to create new treatment opportunities for patients with unmet medical needs.

Explore Our Technology

View Our Pipeline

Our Story

Expanding the Possibilities of Antibody Therapeutics

HumiNex is a biotechnology company focused on creating differentiated antibody therapeutics for areas of high unmet medical need.

By combining antibody design, engineering, and advanced therapeutic modalities, we aim to overcome biological barriers that limit conventional antibody approaches and translate innovative science into meaningful medicines.

Learn More About HumiNex

Our TECHNOLOGY

HMX Discovery Engine

Discovering differentiated antibodies against complex membrane targets.

ISP

Enabling induced internalization of poorly internalizing membrane targets.

ExFc

Engineering Fc properties for optimized pharmacokinetics and effector functions.

Explore Our Technology

LEAD PIPELINE

View Full Pipeline

Let’s Build the Next Therapeutic Opportunity Together